FemDophilus

Fem-Dophilus contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1 and Lactobacillus reuteri, RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote healthy vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.* GR-1/RC-14 and VAGINAL FLORA (also called microbiota) In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement. Martinez, et al. Can J Microbiol 2009;55:133-138

Suggested Use

Usage: For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional.

Dietary Considerations

Wheat Free Gluten Free Soy Free Egg Free Shellfish Free

Warnings

Contains: Dairy (casein, in trace amounts). No wheat, no gluten, no soybeans, no dairy, no egg, no fish/shellfish, no peanuts/tree nuts. Keep refrigerated. Keep out of the reach of children.

Product info

Serving Size: 1 Capsule Servings Per Container: 60 Disclaimer Amount Per Serving Total Probiotic Blend 5 Billion viable cells Composed of the following strains: Lactobacillus rhamnosus, GR-1 Lactobacillus reuteri, RC-14 Other ingredients: Dextrose anhydrate, potato starch, cellulose, magnesium stearate (vegetable source), Capsule consists of gelatin, Capsule consists of titanium dioxide